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Background
Cachexia affects most patients with incurable cancer
impacting quality of life and prognosis especially in the
late stage of disease. While much research has investi-
gated the causes of cancer cachexia, the precise mechan-
isms causing cachexia are still poorly understood.
Concurrently, it is increasingly documented that tumors
function with elevated glycolysis.
Methods and Results
We model an anaerobic component of tumor energy
metabolism to assess its impact and contribution to
cachexia. In this model, with a high level of anaerobic
energy production, the energetic cost to sustain the
tumor may reach or exceed 394 kcal/ day per kg of
tumor. In addition, the tumor’s high level of glucose
and glutamine consumption causes muscle breakdown
to fuel the tumor, especially in the fasting state. We cal-
culate an estimate of the tumor’s energetic cost on the
body in terms of aerobic and anaerobic components, as
well as the Cori cycling cost of recycling lactate gener-
ated by the tumor back into glucose, at varying levels of
tumor mass and of anaerobic energy metabolism.
Conclusions
Our model suggests the energetic drain caused by a
tumor is substantial when anaerobic energy metabolism
is taken into account, and that elevated anaerobic
energy metabolism in cancer may be a key contributor
to cancer cachexia.
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